add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers

Sharonmoyee Goswami

Partner, Litigation

Sharonmoyee Goswami’s practice focuses on intellectual property, antitrust and litigation involving complex scientific issues.

Ms. Goswami’s notable representations include:

  • Represented Amgen in one of the first actions to proceed under the Biologics Price Competition and Innovation Act (BPCIA), which concerned its introduction of a biosimilar to the world’s largest‑selling drug, Humira®. In September 2017, Amgen reached a global settlement with AbbVie, enabling Amgen to market the first approved biosimilar to Humira® in the United States and Europe.
  • Won a jury verdict for Amgen as plaintiff in the February 2019 retrial of a patent infringement case in Delaware federal court against defendants Sanofi, Sanofi affiliates and Regeneron, relating to Amgen’s patents covering a class of biologic drugs that included Amgen’s drug, Repatha®.
  • Representing DRIT LP, an investment vehicle of DRI Capital, in a patent licensing dispute against Glaxo Group Limited and Human Genome Sciences, Inc. (“GSK”) over the lupus drug Benlysta®. In September 2018, a Delaware jury returned a unanimous verdict in favor of DRIT following a six‑day trial. In October 2019, the court denied GSK’s renewed motion for judgment as a matter of law or, in the alternative, for a new trial.
  • Represented Xerox Corporation as plaintiff in a patent infringement action against Google and Yahoo! in Delaware federal court relating to search query technology.
  • Represented Qualcomm in a suit filed by the U.S. Federal Trade Commission (“FTC”) in California federal court alleging violations of Section 5 of the FTC Act and seeking a permanent injunction against Qualcomm.
  • Represented Qualcomm in an antitrust action filed in Pennsylvania federal court alleging that Qualcomm conspired with others to exclude technology owned by TruePosition, Inc. from the 4G LTE cellular standard. The case settled on grounds favorable to Qualcomm.
  • Represented Life Technologies Corporation, a leading life sciences company, on antitrust issues in connection with its $15.8 billion sale to Thermo Fisher Scientific Inc.
  • Advised Grupo Modelo, S.A.B. de C.V. on antitrust issues in connection with its $20.1 billion acquisition by Anheuser-Busch InBev and represented the company in litigation against the U.S. government.
  • Represented NCR Corporation in several environmental actions brought under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), relating to the environmental remediation of Wisconsin’s Fox River and Michigan’s Kalamazoo River, including two trials in federal courts in Michigan and Wisconsin.
  • Represented Spirits International B.V. in an action brought by Classic Liquor Importers, Ltd. in New York federal court seeking a declaratory judgment that its “Royal Elite” vodka does not infringe Spirits’ trademarks on Stolichnaya’s “Elit” vodka.
  • Represented Credit Suisse in RMBS litigation brought by CMFG Life Insurance, which was dismissed with prejudice following a settlement in principle that was reached the morning of the first day of trial.

In 2020, Ms. Goswami was selected to serve as a member of Law360’s Life Sciences Editorial Advisory Board.

Ms. Goswami was born in Washington, D.C. She received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law.

Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019. Ms. Goswami is a partner liaison to the Firm’s South Asian Affinity Group.

Ms. Goswami is admitted to practice in New York and before the Patent and Trademark Office.

Ms. Goswami is admitted only in New York.

+1 (212) 474-1928
+1 (212) 474-3700